4-Ethylcatechol

CAS No. 1124-39-6

4-Ethylcatechol( —— )

Catalog No. M36952 CAS No. 1124-39-6

4-Ethylcatechol is present in red wine and can be extracted from Glechoma longituba (NaKai) Kupr.4-Ethylcatechol induces DNA damage in the presence of Cu(II).4-Ethylcatechol is a potent antiplatelet compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 61 In Stock
25MG 113 In Stock
50MG 181 In Stock
100MG 267 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Ethylcatechol
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Ethylcatechol is present in red wine and can be extracted from Glechoma longituba (NaKai) Kupr.4-Ethylcatechol induces DNA damage in the presence of Cu(II).4-Ethylcatechol is a potent antiplatelet compound.
  • Description
    4-Ethylcatechol is present in red wine and can be extracted from Glechoma longituba (NaKai) Kupr.4-Ethylcatechol induces DNA damage in the presence of Cu(II).4-Ethylcatechol is a potent antiplatelet compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    DNA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1124-39-6
  • Formula Weight
    138.16
  • Molecular Formula
    C8H10O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCc1ccc(O)c(O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ddr1-In-1

    DDR1-IN-1 is an effective and specific?DDR1?receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.

  • VAL-083

    VAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.

  • Sarmustine

    Sarmustine (SarCNU) is an alkylating agent with anticancer activity that inhibits the growth of prostate cancer cells via p53-dependent and p53-independent pathways.